Vivera Pharmaceuticals

[Vivera Pharmaceuticals @ViveraPharma]

Vivera is proud to announce that its Chairman, Founder, and CEO, Paul Edalat, has been named one of the Top 5 Entrepreneurs to Watch in 2024 in a recent USA TODAY article.
https://t.co/A53WqAIOum

[Vivera Pharmaceuticals @ViveraPharma]

Vivera is relieved to share that its litigation involving Pedram Salimpour has been dismissed, leaving Salimour with nothing by way of settlement.

Learn more and find out what @pauledalat, Chairman, Founder, and CEO of Vivera, had to say about the case here:

[Vanguard News Group @DavisVanguard]

Pharmaceutical Company Wins Frivolous Lawsuit Filed by Now Disgraced Attorney Thomas Girardi

https://t.co/xZnThh0h8Q

[Tycoon Success @tycoonsuccess]

Meet @pauledalat Founder & CEO of @ViveraPharma

He used his interests & #entrepreneurialskills for decades to make a difference in the fast-growing #fitness & #wellness sectors.

Read At:- https://t.co/cWd9fUdHqh
#InnovativeSolutions #DrugDelivery #PatientCare #PatientCentricity

[Vivera Pharmaceuticals @ViveraPharma]

Vivera is pleased to announce that the USPTO has issued a U.S. patent allowance for the Company's speech fluency and assessment device. https://t.co/0Q2oVqSzrt

[Vivera Pharmaceuticals @ViveraPharma]

We're thrilled to share that our very own Chairman, CEO, and Founder, Paul Edalat, has been recognized by @CIOLookmagazine as one of the most admired leaders in pharmaceuticals. 🏆 https://t.co/hIM0zGWNBP

[Vivera Pharmaceuticals @ViveraPharma]

People Like You: STREAMING NOW ✨

https://t.co/zfljnkxHkg

[Vivera Pharmaceuticals @ViveraPharma]

Vivera is pleased to welcome Saurabh R. to the Company's Advisory Board. Mr. Radhakrishnan will support Vivera in its development and commercialization initiatives for ZICOH, the Company's high-tech, electronic, dose-controlled medication delivery syste... https://t.co/pwBZ93bHuD

[Vivera Pharmaceuticals @ViveraPharma]

Vivera Appoints World-Renowned Regulatory Leader Dr. Geetha Rao To Advisory Board https://t.co/5ClMDUyT6O

[Vivera Pharmaceuticals @ViveraPharma]

Chairman and CEO of Vivera, @pauledalat, invites @RepDavidTrone to discuss potential solutions to the crisis.

[Vivera Pharmaceuticals @ViveraPharma]

A recently released congressional @JECDems report estimates that opioid addiction has cost the United States nearly $1.5 trillion in 2020. Vivera says it's time to get serious. Learn more: https://t.co/bgro2du4rA

[Vivera Pharmaceuticals @ViveraPharma]

Vivera is pleased to announce that @uspto granted a third U.S. Patent for ZICOH, securing the device's rights as a Secure Smart Dosing System with Automated Delivery, Measurement, and Management for Pills! Learn more:
https://t.co/gVkpTijxJk
#medtech

[Vivera Pharmaceuticals @ViveraPharma]

Vivera proudly supported law enforcement agencies and firefighters for a complex, coordinated terrorist attack exercise. Learn more:
https://t.co/1kS8lAeu6G

[Vivera Pharmaceuticals @ViveraPharma]

CVS, Walmart, and Walgreens must pay a combined $650.6 million to two Ohio counties to address damage related to the opioid crisis: https://t.co/OBhU1swpgN

[Vivera Pharmaceuticals @ViveraPharma]

Congratulations, @pauledalat, on your recognition in C-Suite as a CEO Visionary. Check out the feature: https://t.co/wcL3bldmVk

[Vivera Pharmaceuticals @ViveraPharma]

Vivera is pleased to announce the appointment of Guido Jouret, Ph.D., to the Company's Board of Advisors as Senior Technology Advisor and Interim Chief Technology Officer. Dr. Jouret will assist Vivera in its next phase of growth and development, focuse... https://t.co/NsTjhHCl7O

[Vivera Pharmaceuticals @ViveraPharma]

Vivera welcome Rob (Ram) Massoudi and Bryan Hughes to the Company’s Advisory Board as Senior Technology Advisors. https://t.co/aoSdKLAbuM

[Vivera Pharmaceuticals @ViveraPharma]

❤️💙

[Vivera Pharmaceuticals @ViveraPharma]

This initiative is particularly unique because it will be led by Gerald A Maguire, MD and Shahriar SheikhBahaei, two doctors who stutter and have dedicated their careers towards understanding the disorder.

[Vivera Pharmaceuticals @ViveraPharma]

Vivera Bio, a division of Vivera Pharmaceuticals, is proud to announce that it has executed a LOI to Enter a CRADA with @NINDStrials of @NIH to assess therapeutic agents for the potential treatments of #stuttering disorders.

https://t.co/zjOFgq0e4e

[Vivera Pharmaceuticals @ViveraPharma]

There are many misconceptions about stuttering. We asked Dr. Maguire, what is something you want the world to know about stuttering and people who stutter? This was his response. #StutteringAwarenessWeek